X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ALKEM LABORATORIES - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ALKEM LABORATORIES CADILA HEALTHCARE/
ALKEM LABORATORIES
 
P/E (TTM) x 34.4 - - View Chart
P/BV x 8.9 6.2 144.0% View Chart
Dividend Yield % 0.7 0.7 98.0%  

Financials

 CADILA HEALTHCARE   ALKEM LABORATORIES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
ALKEM LABORATORIES
Mar-16
CADILA HEALTHCARE/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4541,589 28.6%   
Low Rs3051,232 24.7%   
Sales per share (Unadj.) Rs96.1417.5 23.0%  
Earnings per share (Unadj.) Rs14.956.3 26.4%  
Cash flow per share (Unadj.) Rs17.864.7 27.5%  
Dividends per share (Unadj.) Rs3.2012.70 25.2%  
Dividend yield (eoy) %0.80.9 93.7%  
Book value per share (Unadj.) Rs52.3292.9 17.8%  
Shares outstanding (eoy) m1,023.74119.57 856.2%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.93.4 116.9%   
Avg P/E ratio x25.525.1 101.8%  
P/CF ratio (eoy) x21.321.8 97.7%  
Price / Book Value ratio x7.34.8 150.7%  
Dividend payout %21.522.6 95.4%   
Avg Mkt Cap Rs m388,458168,653 230.3%   
No. of employees `00015.4NA-   
Total wages/salary Rs m13,3179,171 145.2%   
Avg. sales/employee Rs Th6,371.1NM-  
Avg. wages/employee Rs Th862.4NM-  
Avg. net profit/employee Rs Th986.1NM-  
INCOME DATA
Net Sales Rs m98,37649,915 197.1%  
Other income Rs m9411,645 57.2%   
Total revenues Rs m99,31751,561 192.6%   
Gross profit Rs m23,8298,482 280.9%  
Depreciation Rs m3,0221,006 300.5%   
Interest Rs m486671 72.5%   
Profit before tax Rs m21,2628,451 251.6%   
Minority Interest Rs m-300-114 263.6%   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,7161,606 355.9%   
Profit after tax Rs m15,2266,731 226.2%  
Gross profit margin %24.217.0 142.5%  
Effective tax rate %26.919.0 141.5%   
Net profit margin %15.513.5 114.8%  
BALANCE SHEET DATA
Current assets Rs m44,37627,062 164.0%   
Current liabilities Rs m34,07115,324 222.3%   
Net working cap to sales %10.523.5 44.5%  
Current ratio x1.31.8 73.8%  
Inventory Days Days5467 81.0%  
Debtors Days Days6241 151.0%  
Net fixed assets Rs m47,89612,610 379.8%   
Share capital Rs m1,024239 428.3%   
"Free" reserves Rs m48,74634,490 141.3%   
Net worth Rs m53,51935,027 152.8%   
Long term debt Rs m8,9641,212 739.8%   
Total assets Rs m100,16354,387 184.2%  
Interest coverage x44.713.6 329.0%   
Debt to equity ratio x0.20 484.2%  
Sales to assets ratio x1.00.9 107.0%   
Return on assets %15.713.6 115.3%  
Return on equity %28.419.2 148.0%  
Return on capital %34.324.9 138.0%  
Exports to sales %45.312.9 349.8%   
Imports to sales %5.93.1 192.3%   
Exports (fob) Rs m44,5376,461 689.3%   
Imports (cif) Rs m5,8381,540 379.0%   
Fx inflow Rs m44,8816,563 683.8%   
Fx outflow Rs m9,0693,012 301.1%   
Net fx Rs m35,8123,552 1,008.3%   
CASH FLOW
From Operations Rs m19,9387,259 274.7%  
From Investments Rs m-9,0391,864 -484.9%  
From Financial Activity Rs m-9,527-9,273 102.7%  
Net Cashflow Rs m1,372-150 -914.7%  

Share Holding

Indian Promoters % 74.8 66.9 111.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 33.1 25.1%  
FIIs % 5.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 0.0 -  
Shareholders   44,069 68,381 64.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Realty Sector Up 2.7%(11:30 am)

After opening the day higher, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 23, 2017 12:35 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - TTK HEALTHCARE COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS